Cargando…
A preclinical study demonstrating the efficacy of nilotinib in inhibiting the growth of pediatric high-grade glioma
Solid tumors arising from malignant transformation of glial cells are one of the leading causes of central nervous system tumor-related death in children. Recurrence in spite of rigorous surgical and chemoradiation therapies remains a major hurdle in management of these tumors. Here, we investigate...
Autores principales: | Au, Karolyn, Singh, Sanjay K., Burrell, Kelly, Sabha, Nesrin, Hawkins, Cynthia, Huang, Annie, Zadeh, Gelareh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436849/ https://www.ncbi.nlm.nih.gov/pubmed/25732621 http://dx.doi.org/10.1007/s11060-015-1744-y |
Ejemplares similares
-
Investigation of the In Vitro Therapeutic Efficacy of Nilotinib in Immortalized Human NF2-Null Vestibular Schwannoma Cells
por: Sabha, Nesrin, et al.
Publicado: (2012) -
Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma
por: Bikhezar, Fatima, et al.
Publicado: (2019) -
Preclinical studies of 5-fluoro-2′-deoxycytidine and tetrahydrouridine in pediatric brain tumors
por: Morfouace, Marie, et al.
Publicado: (2015) -
Blocking COX-2 induces apoptosis and inhibits cell proliferation via the Akt/survivin- and Akt/ID3 pathway in low-grade-glioma
por: Sato, Aya, et al.
Publicado: (2017) -
Isthmin inhibits glioma growth through antiangiogenesis in vivo
por: Yuan, Bangqing, et al.
Publicado: (2012)